PALYNZIQ Trademark

Trademark Overview

On Wednesday, July 6, 2016, a trademark application was filed for PALYNZIQ with the United States Patent and Trademark Office. The USPTO has given the PALYNZIQ trademark a serial number of 87095019. The federal status of this trademark filing is REGISTERED as of Tuesday, October 9, 2018. This trademark is owned by Biomarin Pharmaceutical Inc.. The PALYNZIQ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapy
palynziq

General Information

Serial Number87095019
Word MarkPALYNZIQ
Filing DateWednesday, July 6, 2016
Status700 - REGISTERED
Status DateTuesday, October 9, 2018
Registration Number5581302
Registration DateTuesday, October 9, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 29, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for use in enzyme therapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 12, 2016
Primary Code005
First Use Anywhere DateMonday, July 2, 2018
First Use In Commerce DateMonday, July 2, 2018

Trademark Owner History

Party NameBiomarin Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Tuesday, July 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 9, 2016NEW APPLICATION ENTERED
Wednesday, July 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 14, 2016ASSIGNED TO EXAMINER
Monday, October 17, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 9, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 29, 2016PUBLISHED FOR OPPOSITION
Tuesday, November 29, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 24, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 10, 2017SOU TEAS EXTENSION RECEIVED
Monday, July 10, 2017SOU EXTENSION 1 FILED
Monday, July 10, 2017SOU EXTENSION 1 GRANTED
Thursday, September 6, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, January 18, 2018SOU TEAS EXTENSION RECEIVED
Thursday, January 18, 2018SOU EXTENSION 2 FILED
Thursday, January 18, 2018SOU EXTENSION 2 GRANTED
Saturday, January 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 23, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 23, 2018TEAS STATEMENT OF USE RECEIVED
Monday, July 23, 2018USE AMENDMENT FILED
Monday, August 20, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, August 20, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, September 7, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 9, 2018REGISTERED-PRINCIPAL REGISTER
Wednesday, December 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 9, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, December 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 30, 2024TEAS SECTION 8 & 15 RECEIVED
Monday, October 9, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

palynziq pharmaceutical preparations enzyme therapy disorders genetic treatment diseases